WallStSmart

Equinix Inc (EQIX)vsSabra Healthcare REIT Inc (SBRA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Equinix Inc generates 1068% more annual revenue ($9.53B vs $815.66M). SBRA leads profitability with a 19.2% profit margin vs 14.9%. EQIX appears more attractively valued with a PEG of 3.45. SBRA earns a higher WallStSmart Score of 59/100 (C).

EQIX

Buy

54

out of 100

Grade: C-

Growth: 6.7Profit: 6.5Value: 3.0Quality: 3.5
Piotroski: 3/9Altman Z: 0.55

SBRA

Buy

59

out of 100

Grade: C

Growth: 5.3Profit: 7.0Value: 6.0Quality: 5.5
Piotroski: 3/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EQIX.

SBRAUndervalued (+84.2%)

Margin of Safety

+84.2%

Fair Value

$124.38

Current Price

$18.46

$105.92 discount

UndervaluedFair: $124.38Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EQIX3 strengths · Avg: 8.3/10
Market CapQuality
$105.71B9/10

Large-cap with strong market position

Operating MarginProfitability
24.3%8/10

Strong operational efficiency at 24.3%

EPS GrowthGrowth
20.0%8/10

Earnings expanding 20.0% YoY

SBRA3 strengths · Avg: 8.7/10
Operating MarginProfitability
31.4%10/10

Strong operational efficiency at 31.4%

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
21.7%8/10

Revenue surging 21.7% year-over-year

Areas to Watch

EQIX4 concerns · Avg: 2.5/10
Debt/EquityHealth
1.633/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.452/10

Expensive relative to growth rate

P/E RatioValuation
74.1x2/10

Premium valuation, high expectations priced in

SBRA4 concerns · Avg: 3.0/10
P/E RatioValuation
29.7x4/10

Moderate valuation

Return on EquityProfitability
5.6%3/10

ROE of 5.6% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
5.282/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : EQIX

The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth. Revenue growth of 12.1% demonstrates continued momentum.

Bull Case : SBRA

The strongest argument for SBRA centers on Operating Margin, Price/Book, Revenue Growth. Profitability is solid with margins at 19.2% and operating margin at 31.4%. Revenue growth of 21.7% demonstrates continued momentum.

Bear Case : EQIX

The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 74.1x leaves little room for execution misses. Debt-to-equity of 1.63 is elevated, increasing financial risk.

Bear Case : SBRA

The primary concerns for SBRA are P/E Ratio, Return on Equity, Piotroski F-Score.

Key Dynamics to Monitor

EQIX profiles as a value stock while SBRA is a growth play — different risk/reward profiles.

EQIX carries more volatility with a beta of 1.00 — expect wider price swings.

SBRA is growing revenue faster at 21.7% — sustainability is the question.

SBRA generates stronger free cash flow (98M), providing more financial flexibility.

Bottom Line

SBRA scores higher overall (59/100 vs 54/100), backed by strong 19.2% margins and 21.7% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Equinix Inc

REAL ESTATE · REIT - SPECIALTY · USA

Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.

Visit Website →

Sabra Healthcare REIT Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 skilled nursing / transitional care facilities, (ii) 64 senior housing communities (?

Want to dig deeper into these stocks?